We hear from Jonny Acheson and Clare Addison, two healthcare professionals based in England who have decided to step back from their hospital roles during the Covid-19 pandemic, about why the UK’s National Health Service (NHS) will “never be the same again”
How has the Covid-19 pandemic affected you as NHS workers who are living with Parkinson’s?
Clare Addison, surgical matron: It’s changed my role completely. Having Parkinson’s doesn’t mean you have an increased risk of getting Covid-19 but if you do get it, you will likely have a slower recovery path, meaning you could deprive someone else of valuable medical attention. We need to be socially responsible to enable resources for those who need it. So, after hard conversations with my managers, it was clear that I needed to work from home.
It has been challenging for me to accept that I need to step aside from being a healthcare professional and be at home. Being in a senior position, people look up to me for guidance and leadership – so to take myself away from that has been difficult.
Jonny Acheson, A&E consultant: When the guidance came out about people with Parkinson’s having an increased risk, I had to decide what’s best for me as a person with Parkinson’s versus as a trained healthcare professional. Whatever your role is in the NHS, if you are living with Parkinson’s or any high-risk condition, you are torn between what your heart says and what your mind says because you’re trained to deliver a service.
I told my team that someone needs to make this decision for me and that’s what they did.
I’m currently trying to give support from a distance, such as offering telephone support for staff. Team members can ring me whenever they are struggling at work or need to talk. Although we are self-isolating, we’re not cut off from the service and our colleagues. I’ve been drawing some NHS sketches for my team to show my support through pictures as a way of raising morale.
Can you give an insight into how the pandemic is affecting NHS workers?
Jonny: It is unprecedented. We’ve had SARS, swine flu and bird flu, but we’ve never had anything like this before and I don’t think we ever will. There’s anxiety about how quickly this disease gets people and it will unfortunately cause many deaths.
The NHS has gone into a different gear and barriers that were once there are suddenly disappearing. Everyone has gone into the mode of ‘we can do this, we have to do this, and we will do this’. I went to Sainsbury’s supermarket this morning and people were clapping for me. In times of crisis, people really do get behind the NHS.
Clare: There has been a lot of staff refresher training, staff moving to different areas that are in need and adjusting to the new ways of working. What has been incredible is people’s willingness to adapt – you can see they are frightened and anxious but they’re just getting on with it. Covid-19 will change the NHS forever, some of our old and convoluted processes have gone and I don’t see how they will come back. People’s skillsets are going to have been refreshed and broadened.
What would you say to people in the Parkinson’s community that may be struggling physically or emotionally?
Jonny: There is currently an information overload, so if you want to keep up-to-date with coronavirus news, look at vetted sources. I’ve turned notifications off on my devices to give myself some headspace. I don’t think it is helpful to try and predict what is going to happen with Covid-19, instead take each day as it comes and try to live the best you can. Also, keep exercising and make sure you are finding other ways to socialise while socially distancing.
Clare: My mum has Parkinson’s and she told me on a Skype call, “I need you to know that I don’t want to go to hospital, and I am happy to die alone”. That’s a really hard conversation to have with your mother but actually it’s a helpful conversation in some respects because it shows she’s thinking about it.
How does it make you feel to be part of the NHS during this period?
Clare: Massively proud. Although it is frustrating not being in the hospital, we are both doing our bit in other ways. It’s amazing seeing everyone coming together – those who are just starting out, people coming back from retirement and those volunteering. There are definitely struggles to come but there are some positives too.
Jonny: It’s brilliant. This is showing talent and skillsets in workers that we have never seen before, coming out of their shells and becoming leaders. Every time you pick up the badge and see NHS, it feels very symbolic – the NHS won’t be the same again.
Jonny Acheson is an A&E consultant at the University Hospitals of Leicester and works in University of Leicester Medical School in Leicester, UK. Since his Parkinson’s diagnosis in 2016, his role changed from working on the frontline to working mainly in observation wards in the hospital.
Clare Addison is a matron for surgery at Surrey and Sussex Healthcare NHS Trust and is the co-lead of the Parkinson’s UK Excellence Network for the south east of England. Clare was diagnosed with Parkinson’s in 2016 and has a clinical background as a neuroscience specialist nurse.
How have you been affected by the coronavirus?
We will be doing all we can to share useful information about Covid-19 with you as the situation develops – and we need your help. To share your experience or tell us the topics you want Parkinson’s Life to cover during the pandemic, please leave a comment or email firstname.lastname@example.org.
For more information about Parkinson’s and coronavirus please visit the EPDA website.
Vegetarian ‘Beet Wellington’ with mushrooms, aubergines and garlic
A vegetarian twist on a steak classic
2 days ago
Scientists at MIT uncover new clues about Parkinson’s disease
Neuroscientists at Massachusetts Institute of Technology (MIT), US, have developed new tools that could improve understanding of Parkinson’s disease. As part of a study, published in Science Advances, the tools were used on animals to investigate the relationship between two types of signals that are disrupted in Parkinson’s – dopamine signalling and beta-band oscillations (coordinated waves of electrical activity in the brain). The scientists found that while the animals performed certain tasks, beta-band oscillations increased while dopamine signalling declined in particular parts of the brain. Factors including an animal’s past experience and the reward value of a task also impacted the relationship between the two signals. Helen Schwerdt, a research scientist at MIT, said: “Considering electrical signals side by side with chemical signals is really important to understand how the brain works.” Ann Graybiel, a professor at MIT, added: “As these methods in neuroscience become more and more precise and…
People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds
A new database study of around 80,000 Covid-19 patients has found that those living with Parkinson’s disease have a 30% higher risk of dying from the virus than those without the condition. The study – conducted by researchers at the University of Iowa Health Care, US – identified that Covid-19 patients with Parkinson’s disease were generally older, more likely to be male and less likely to be African American. As these factors could also affect the risk of death from Covid-19, the researchers adjusted their statistical models to account for differences in sex, age and race and found a significantly higher risk of dying from Covid-19 in the group of patients with Parkinson’s disease. Lead researcher Dr Nandakumar Narayanan said: “We recognise the limitations of this study; it is retrospective data from a single database, but we are confident that these data show that Parkinson’s disease is [an] independent risk factor…
BIAL enters the US and acquires “promising” Parkinson’s disease programmes
Portugal-based pharmaceutical company BIAL has launched a new research centre, BIAL Biotech, in Massachusetts, US, which will focus on genetically defined Parkinson’s disease. BIAL has also announced that it has acquired the Parkinson’s disease research programmes of Lysosomal Therapeutics Inc, as well as its research and development team and clinical programme for LTI-291 – a therapy designed to treat a genetic form of the condition. António Portela, executive president of BIAL, said: “Our entry into the US with the creation of BIAL Biotech and the acquisition of the promising programmes from LTI, is a decisive step towards the fulfilment of our mission to contribute to improving the quality of life of people worldwide. “The development of this new research centre in the US, is a landmark of enormous relevance for us. We are investing in science and research, through our direct presence in one of the most important research hubs…